News & Events

Filter By:
Subscribed

    20 June
    2024
    Inspira™ Announces Business Plan Targets
    Read More
    17 June
    2024
    Inspira™ Introduces Advanced Life Support Solutions to Key International Leaders at the Annual iECOs Conference in Israel
    Read More
    13 June
    2024
    Inspira™ Receives First Ever Purchase Order for INSPIRA™ ART100 Systems in the U.S.
    Read More
    05 June
    2024
    Inspira™ to Exhibit the FDA Cleared INSPIRA™ ART100 System at a World-Renowned Event in the Sector
    Read More
    30 May
    2024
    Inspira™ Technologies Announces Business Targets Presentation Following FDA Clearance and Significant Developments
    Read More
    28 May
    2024
    INSPIRA™ ART100 Receives FDA 510(k) Clearance
    Read More
    02 May
    2024
    Inspira™ Announces Start of Production of the INSPIRA™ ART100
    Read More
    25 April
    2024
    Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
    Read More
    16 April
    2024
    Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
    Read More
    10 April
    2024
    Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
    Read More
    07 April
    2024
    Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
    Read More
    01 April
    2024
    Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO’s Mother with Leading Fund Manager
    Read More
    25 March
    2024
    Inspira™ Technologies Reports Full Year 2023 Financial Results
    Read More
    18 March
    2024
    Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets
    Read More
    12 March
    2024
    Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
    Read More
    04 March
    2024
    Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days
    Read More
    04 March
    2024
    Company Conference Call – March 2024
    Read More
    27 February
    2024
    Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone
    Read More
    27 February
    2024
    Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
    Read More
    22 February
    2024
    Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies
    Read More
    14 February
    2024
    Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
    Read More
    08 February
    2024
    Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device
    Read More
    30 January
    2024
    Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices
    Read More
    09 January
    2024
    Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity
    Read More
    28 December
    2023
    Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering
    Read More
    26 December
    2023
    Inspira™ Announces $3.88 Million Registered Direct Offering
    Read More
    26 December
    2023
    Inspira™ Announces 95% Accuracy Results for HYLA™ Blood Sensor, Planning FDA Submission for Clearance in 2024
    Read More
    18 December
    2023
    Inspira™ Technologies to Participate in J.P. Morgan Healthcare Conference
    Read More
    11 December
    2023
    In Preparation for FDA Clearance and Device Deployment, Inspira™ has Appointed Dr. Dan Gorfil, to Medical Advisory Board
    Read More
    29 November
    2023
    Inspira™ Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
    Read More
    16 November
    2023
    Inspira™ Technologies Reports Third Quarter 2023 Financial Results
    Read More
    06 November
    2023
    Inspira™ Announces Israeli Innovation Authority Grant for New VORTX™ Disposable Blood Oxygenation Technology
    Read More
    25 October
    2023
    Inspira™ Granted U.S. Patent for INSPIRA™ ART500 Medical Device
    Read More
    24 October
    2023
    Inspira™ Terminates ATM Program and Provides an Update
    Read More
    10 October
    2023
    Inspira™ Enters into a Distribution Agreement in Central America with CIO MED GROUP
    Read More
    13 September
    2023
    Inspira™ Announces 510(k) FDA Submission of INSPIRA™ ART100 Towards Commercialization
    Read More
    31 August
    2023
    Inspira™ Signs Agreement Expansion with Innovimed for Clinical Trials of INSPIRA™ ART Respiratory Medical Devices
    Read More
    10 August
    2023
    Inspira™ Technologies Reports Second Quarter 2023 Financial Results
    Read More
    09 August
    2023
    INSPIRA™ ART100 Completes Usability Study in Boston Massachusetts, U.S.
    Read More
    24 July
    2023
    Inspira™ Technologies Receives Certification of Medical Devices Quality Management Systems, Another Step Towards EU Regulatory Approval
    Read More
    19 July
    2023
    Inspira™ Technologies Enters into Collaboration Agreement with U.S.-Based Perfusion Solution Inc.
    Read More
    15 June
    2023
    Inspira™ Technologies Unveils Investor Deck Showcasing Revolutionary Advancement in Acute Respiratory Care
    Read More
    30 May
    2023
    Inspira Technologies Appoints Dr. Nir as Chief Medical Officer
    Read More
    18 May
    2023
    Inspira™ Technologies Reports First Quarter 2023 Financial Results
    Read More
    16 May
    2023
    Inspira™ Technologies will Reveal the New ALICE™ Device at the World’s Largest Extracorporeal Life Support Conference
    Read More
    11 May
    2023
    Inspira™ Technologies is Developing the VORTX™ Blood Oxygenator, a Unique Technology for Saturating Blood With Oxygen and Removing Carbon Dioxide
    Read More
    04 April
    2023
    Inspira™ Technologies Reports Fourth Quarter 2022 and Full Year Financial Results
    Read More
    22 March
    2023
    Inspira™ Technologies Announces First in Human of HYLA™ Blood Sensor in Clinical Study
    Read More
    10 March
    2023
    VP operations presents the start of ALICE™ Device manufacturing
    Read More
    13 February
    2023
    Inspira™ Technologies Receives Approval from Sheba Medical Center to Conduct Clinical Study of the HYLA™ Blood Sensor
    Read More
    23 January
    2023
    Inspira™ Technologies Granted Patent by U.S. Patent Office for the INSPIRA™ ART System’s Convertible Dual Lumen Cannula Device and Method of Use
    Read More
    10 January
    2023
    Diamond Equity Research Initiates Coverage on Inspira Technologies Ltd. (NASDAQ: IINN)
    Read More
    04 January
    2023
    Creating a Paradigm Shift in Respiratory Care: Early Respiratory Support Reducing the Need for Invasive Mechanical Ventilation / by HAARETZ
    Read More
    27 December
    2022
    Inspira™ Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
    Read More
    25 December
    2022
    VP clinical affairs video presents the upcoming clinical trial in Sheba hospital
    Read More
    20 December
    2022
    Inspira™ Technologies Begins Manufacturing of the ALICE™ CPB Device, Ahead of Planned 2023 FDA Submission
    Read More
    14 December
    2022
    Inspira™ Technologies Signs Agreement to Conduct Clinical Study of HYLA™ Blood Sensor
    Read More
    23 November
    2022
    Inspira™ Technologies Reports Third Quarter 2022 Financial Results
    Read More
    22 November
    2022
    Inspira™ Technologies Signs a Strategic Agreement in Europe to potentially provide $26.1 Million for Deployment of 1,364 HYLA™ Blood Sensors
    Read More
    10 November
    2022
    Inspira™ Technologies Granted Patent by the Israeli Patent Office for Key Safety Component for the INSPIRA™ ART System
    Read More
    08 November
    2022
    Inspira™ Technologies to Present Advanced Respiratory Solutions to Key International Leaders at the Annual iECOs Conference in Tel Aviv, Israel
    Read More
    07 September
    2022
    Inspira™ Technologies Performed HYLA™ Blood Sensor In-Vivo Study, in Preparation of Planned Human Studies
    Read More
    01 September
    2022
    Inspira™ Technologies to Present at the H.C. Wainwright 24th Annual Global Investor Conference
    Read More
    11 August
    2022
    Inspira™ Technologies Reports Second Quarter 2022 Financial Results
    Read More
    07 July
    2022
    Inspira™ Technologies Signs Strategic Agreement in U.S. to potentially provide $59 million for Inspira for deployment of 3,889 HYLA™ Blood Sensors
    Read More
    06 July
    2022
    Inspira™ Technologies Develops a Non-Invasive Blood Sensor Designed to Alert Real-Time Change in Patients – Potentially Targets $2.5 Billion ABG Market
    Read More
    08 June
    2022
    Inspira™ Technologies Strategically Plans to Actualize Hundreds of Millions in Conditional Distribution Agreements / by Benzinga
    Read More
    19 May
    2022
    Inspira™ Technologies Announces 2022 first Quarter Financial Results
    Read More
    03 May
    2022
    Inspira™ Technologies to Participate in Upcoming Events in May
    Read More
    27 April
    2022
    The Disruptive MedTech Company Aiming to Minimise Patients’ Need for Invasive Mechanical Ventilation Intervention / by Campden FB
    Read More
    06 April
    2022
    Inspira Technologies Announces Deployment Agreement in the Israeli Market to Target $15M
    Read More
    31 March
    2022
    Inspira Technologies Releases Q4 & FY2021 Financial Results
    Read More
    31 March
    2022
    Inspira Technologies Releases Q4 & FY2021 Financial Results – CEO Update
    Read More
    15 March
    2022
    Inspira Technologies will present its “artificial lungs” technology in front of family offices from all over the world
    Read More
    10 March
    2022
    Inspira Technologies, The Company That Aims To Change 50 Years Of Therapeutic Paradigm In Patients With Respiratory Failure
    Read More
    28 February
    2022
    Inspira Technologies Is Awarded the 2021 Frost & Sullivan Technology Innovation Leadership Award
    Read More
    27 February
    2022
    Inspira Technologies – Awarded with the 2021 Frost & Sullivan Best Practices Technology Innovation Leadership Award
    Read More
    16 February
    2022
    The Respiratory Care Market – Factors Driving the Market and Opportunities for Inspira Technologies’ Products
    Read More
    10 February
    2022
    Inspira Technologies to Present at the Aegis Capital Corp. Virtual Conference
    Read More
    03 February
    2022
    Inspira Technologies Appointed an Expert in the Field of Artificial Lung as the New Chief Technology Officer (CTO)
    Read More
    31 January
    2022
    Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period, Subject to Regulatory Approvals
    Read More
    31 January
    2022
    Inspira Technologies Signs a Strategic Agreement in the U.S. to Target $212 Million for Inspira Over a 7-Year Period
    Read More
    28 January
    2022
    Inspira Technologies Has Listed an FDA Class I 510(k) Exempt component of the ART system
    Read More
    19 January
    2022
    Professor Daniel Brodie, Director of Critical Care from New-York Columbia – Presbyterian Hospital, Has Joined Inspira Technologies’ Advisory Board
    Read More
    09 December
    2021
    Inspira Technologies Signs Strategic Agreement with Innovimed
    Read More
    08 December
    2021
    Inspira Technologies Files a PCT Patent Application for its Flagship ART Device and Proprietary Method of Use
    Read More
    30 November
    2021
    Prof Eddy Fan has joined Inspira’s Scientific Advisory Board
    Read More
    23 November
    2021
    Third Quarter Financial Reports Results
    Read More
    23 November
    2021
    Inspira Technologies Announces 2021 Third Quarter Financial Results; In October 2021, Company increases cash balance by $9.4 Million due to investors Exercising Warrants
    Read More
    22 November
    2021
    Dr. Stephane Ledot, an Expert in Critical Care and Anesthesia, Has Joined Inspira Technologies’ Scientific Advisory Board
    Read More
    16 November
    2021
    Joe Hayon Presents at the H.C. Wainright 7th Annual Israel Conference
    Read More
    14 November
    2021
    Inspira to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference
    Read More
    10 November
    2021
    Inspira Technologies Files a PCT Patent Application for its Novel Dual Lumen Cannula Used for Blood Oxygenation
    Read More
    28 October
    2021
    Has COVID changed the game and what are the opportunities for Inspira’s ART device? Dr. Kassif, The Chairman of the Israeli ECMO Society
    Read More
    26 October
    2021
    Inspira Technologies Signs a Strategic Agreement With Waas Group
    Read More
    25 October
    2021
    “Millions May Soon Breath Better” – Inspira at Forbes
    Read More
    14 October
    2021
    Inspira Technologies to Present In-Person at the HLTH Conference in Boston
    Read More
    30 September
    2021
    Inspira Technologies to Host COVID-19 Virtual Conference on October 6
    Read More
    22 September
    2021
    Inspira Technologies’ “Artificial Lung” to Acquire a Digital Edge: The Company Contracted GlobalLogic, a Hitachi Group Company, for Advanced Digital Product Engineering Services
    Read More
    22 September
    2021
    Inspira Technologies’ “Artificial Lung” To Acquire A Digital Edge: The Company Contracted GlobalLogic, A Hitachi Group Company, For Advanced Digital Product Engineering Services
    Read More
    15 September
    2021
    Inspira Technologies Files a Patent Application for a Supportive Device to be Utilized with the ART Device
    Read More
    12 September
    2021
    Listen To Joe Hayon, Inspira-Technologies’ President, CFO & Co-Founder, Sharing Inspira’s Sharing The Company’s Go-To-Market Strategy
    Read More
    09 September
    2021
    Inspira Technologies to Participate in Upcoming Conferences in September
    Read More
    13 August
    2021
    Inspira Technologies Announces First Half 2021 Financial Results and Provides Business Update
    Read More
    10 August
    2021
    Inspira Technologies Expands Board of Directors to Accelerate Company’s Go-to-Market Efforts
    Read More
    10 August
    2021
    Low Flow Extracorporeal Oxygenation Approach Is The Future Of Acute Respiratory Care
    Read More
    06 August
    2021
    An Interview With Dagi Ben-Noon, CEO At Inspira Technologies
    Read More
    05 August
    2021
    Top 115 Medical And Healthcare Startups In Israel
    Read More
    02 August
    2021
    EXCLUSIVE: Inspira Aims To Replace Mechanical Ventilation With Augmented Respiratory Technology
    Read More
    26 July
    2021
    Inspira Expands Medical Advisory Board as Part of Future Expansion into North American Market
    Read More
    22 July
    2021
    10+ Best Healthcare Startups: Inspiration And Brave Findings Nearby
    Read More
    19 July
    2021
    Inspira Technologies and Ben-Gurion University Have Developed a Platform Designed to Prevent Blood Clotting in Inspira’s ART System
    Read More
    16 July
    2021
    Inspira Technologies Reached Important Milestone as It Completed a Pump Bench Study
    Read More
    16 July
    2021
    Inspira Technologies OXY B.H.N. Ltd Announces Closing of Initial Public Offering
    Read More
    13 July
    2021
    Inspira Technologies OXY B.H.N. Ltd Announces Pricing of Initial Public Offering
    Read More
    28 June
    2021
    The Future Of Respiratory By Inspira Technologies: Breathing Without Lungs
    Read More
    16 June
    2021
    INSPIRA-Technologies Announces New Medical Advisory Board Member – Dr. Avraham Abutbul – Specialist in Internal Medicine, General Intensive Care Medicine and Pulmonary Medicine
    Read More
    20 May
    2021
    Inspira’s Proprietary Augmented Respiration Technology (ART)
    Read More
    14 April
    2021
    Q&A: An Intelligent Oxygenation System That Could Eliminate Need For Ventilators
    Read More
    31 March
    2021
    This IPO Stock Resembles Nanox, Is Inspira IINN Stock A Buy
    Read More
    29 March
    2021
    Breakthrough Oxygenation | Professor Benad Goldwasser
    Read More
    18 March
    2021
    Hillel’s Tech Corner: Inspira Makes Breathing Easy
    Read More
    04 March
    2021
    Inspira Technologies
    Read More
    24 February
    2021
    Inspira Technologies Appoints Benad Goldwasser As Chairman Of The Board
    Read More
    17 February
    2021
    Inspira Technologies and Sheba Medical Center Collaborate on Breakthrough Respiration Treatment
    Read More
    17 February
    2021
    Sheba And Inspira Technologies Implement Respiratory Treatment For Covid-19 Patients
    Read More
    10 December
    2020
    Inspira Technologies Reveals the AXT – An Intelligent System that Directly Oxygenates Blood for Respiratory Care
    Read More
    03 December
    2020
    Inspira Technologies Files U.S. Patent Application for its Innovative Respiratory Support Technology; Engages Leading U.S. Investment Bank for NASDAQ Listing
    Read More

    Get in Touch!

      Ha-Tidhar St 2, Ra'anana, Israel

      I consent to receive emails from Inspira Technologies Oxy B.H.N LTD. To request removal from the mailing list at any time, please send an email to info@inspirao2.com. You can find out about your rights and privacy choices, and how we use your information in our Privacy Policy.

      Join Our Newsletter!

      Sign up and be the first to get notified on new updates of Inspira Technologies

        Copyright © 2018-2022 Inspira-Technologies OXY B.H.N. LTD., All rights reserved